N. Shen

Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system

V. Lorusso, M. Kirchin, G. Pirovano, 2015, Journal of magnetic resonance imaging : JMRI.

Safety characteristics of gadobenate dimeglumine: Clinical experience from intra‐ and interindividual comparison studies with gadopentetate dimeglumine

F. Shellock, M. Kirchin, A. Spinazzi, 2006, Journal of magnetic resonance imaging : JMRI.

Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children

M. van Buchem, P. Demaerel, C. Christophe, 2005, Pediatric Radiology.

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)

J. Weichet, M. Spampinato, A. Bonafe, 2015, American Journal of Neuroradiology.

Gadobenate Dimeglumine‐Enhanced Magnetic Resonance Angiography of the Pelvic Arteries

G. Marchal, M. Oudkerk, M. Knopp, 2003, Investigative radiology.

Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.

N. Rofsky, D. Bloomgarden, R. Semelka, 2015, AJR. American journal of roentgenology.

Gadobenate dimeglumine‐enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto‐iliac stenoses compared to digital subtraction angiography

M. Taupitz, L. Bonomo, R. Manfredi, 2007, Journal of magnetic resonance imaging : JMRI.

Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.

G. Soulez, M. Kirchin, G. Schneider, 2011, European journal of radiology.